Sawada Shigeki, Shiono Satoshi, Yamashita Yoshinori, Tagawa Tsutomu, Ito Hiroyuki, Sato Toshihiko, Harada Hiroaki, Yamashita Motohiro
Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemoto-chou, Matsuyama, Ehime, 791-0280, Japan,
Gen Thorac Cardiovasc Surg. 2015 Apr;63(4):231-8. doi: 10.1007/s11748-014-0506-7. Epub 2014 Dec 18.
Although follow-up surveillance after resection for lung cancer is commonly performed in clinical practice, there is no standard follow-up program. We attempted to establish follow-up examination schedules that we considered would be acceptable to the majority of doctors, and would like to propose them as standard postoperative follow-up pathways.
We carried out a retrospective analysis of patients' data and reviewed the time of detection of recurrence and the site of recurrence after resection. Published papers were also reviewed. The postoperative follow-up pathways were established based on these data.
PROPOSED FOLLOW-UP PATHWAY: The follow-up period was set at as 5 years after resection, and physical examinations, chest radiography, chest CT and blood examination are recommended. Two follow-up pathways were proposed taking the risk of recurrence into consideration: the Risk of recurrence-based pathway and the Comprehensive pathway. In the Risk of recurrence-based pathway, the follow-up examination schedule is modified according to the risk of recurrence. In the Comprehensive pathway, a single universal examination schedule is recommended for all patients. The choice between these two pathways is left to the discretion of the attending doctor.
We proposed two follow-up pathways, based on retrospective analysis of patients' data and a review of published papers, which we considered would be acceptable to the majority of doctors and would be suited to the current medical environment in Japan. A prospective study to evaluate the efficacy of the follow-up pathways is ongoing.
尽管肺癌切除术后的随访监测在临床实践中普遍开展,但尚无标准的随访方案。我们试图制定我们认为大多数医生能够接受的随访检查时间表,并将其作为标准的术后随访路径推荐。
我们对患者数据进行回顾性分析,审查切除术后复发的检测时间和复发部位。还查阅了已发表的论文。基于这些数据建立术后随访路径。
随访期设定为切除术后5年,建议进行体格检查、胸部X线摄影、胸部CT和血液检查。考虑到复发风险,提出了两种随访路径:基于复发风险的路径和综合路径。在基于复发风险的路径中,随访检查时间表根据复发风险进行调整。在综合路径中,建议对所有患者采用单一通用的检查时间表。这两种路径的选择由主治医生自行决定。
基于对患者数据的回顾性分析和对已发表论文的审查,我们提出了两种随访路径,我们认为大多数医生能够接受,并且适合日本当前的医疗环境。一项评估随访路径疗效的前瞻性研究正在进行中。